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Breast cancer is a commonly diagnosed cancer and targets 1 in 8 women in the United States, 
annually.  Certain changes in DNA can induce normal cells to become abnormal, and a 
contributor to this is a gene called Myc, which has shown to be overexpressed in many cancers, 
including breast cancer.  Myc was one of the first discovered oncogenes and it functions as a 
transcription factor that regulates nearly 15% of the genome.  When Myc is mutated in cancer, 
called c-Myc, it functions abnormally and activates pro-survival and pro-proliferative pathways. 
Although decades of research have proven that it could serve as a promising chemotherapeutic 
target because it plays such an important role in cellular division, metabolism, and apoptosis, 
there has been no therapeutic success.  Its dysregulation causes uncontrolled cell growth, which 
is a hallmark of cancer.  Furthermore, overexpression of GLUT glucose transporter proteins can 
facilitate the development of many cancer types due to higher than normal glucose metabolism, 
named the Warburg effect.  Nutritional supplementations, such as omega-3 (n-3) polyunsaturated 
fatty acids (PUFAs), have been known to lower the chances of developing cancer, especially in 
breast cancer.  Preliminary evidence suggests that docosahexaenoic acid (DHA), an omega-3 
fatty acid, has been found to inhibit cancer cell growth and alters the phosphorylation status of 
Myc.  Analysis of Myc phosphorylation sites, which is critical for determining downstream Myc 
targets will provide a better understanding of the anti-cancer properties of DHA and examine the 
consequences of these alterations in breast cancer.  Contributions to this research that has vast 







 While there are many conventional forms of treatment for cancer, including 
chemotherapy and radiation, often times there are many adverse side effects, such as hair loss, 
nausea and fatigue.  There is no guarantee that these treatments are successful.  Not only does 
chemotherapy directly kill cancer cells, normal tissues are affected as well.  The issue today is 
finding an alternative way to completely eliminate cancerous cells.  For many years, it was 
sought that dietary factors can prevent or even treat cancer.  Our lab is focusing on how 
nutritional supplementation may play a role in preventing the growth of tumors or cancerous 
cells.  
 Our lab focuses on combining nutritional supplementation and conventional cancer 
therapies.  We have been investigating polyunsaturated fatty acids (PUFAs), more specifically 
omega-3 fatty acids, to use in cancer remedies.  Omega-3 (n-3) fatty acids have been found to 
have many health benefits towards the heart, brain and muscles, as well as lower incidences of 
developing cancer.  In the 1970s, epidemiological studies showed that Inuit Eskimos who 
consumed high amounts of omega-3 fat obtained from fish had less incidences of developing 
cancer.  The lab has determined the docosahexaenoic acid (DHA), an n-3 fatty acid, has been 
found to inhibit cancer cell growth.  Preliminary evidence suggests that DHA alters Myc protein 
expression and its transcriptional activity in cancer cells. 
 Myc is a regulator gene that is absolutely essential for survival and plays a large role in 
proper cell division, which codes for a transcription factor for other genes.  Myc was one of the 
first discovered oncogenes and it functions as a transcription factor that regulates nearly 15% of 
the genome
1
.  Overexpression of Myc can lead to tumor formation
2
.  Myc is a potent oncogene 
and because it serves such an important role in cell division and acts as a transcription factor for 
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other oncogenes, its dysregulation causes uncontrolled cell growth, which is a hallmark of 
cancer.  This dysregulation will cause Myc to transition from proliferation to differentiation
2,3
.  
When Myc is mutated it is called c-Myc, the most common Myc isoforms found in cancer, it will 
persistently function and be expressed abnormally.   
 Abnormal cancer cell growth can be analyzed by using antibodies specific to c-Myc.  
Oncogenic activity of c-Myc conserved by threonine 58 (T58) and serine 62 (S62) 
phosphorylation sites will be used to regulate c-Myc protein stability in response to mitogenic 
signaling and have been observed in human cancer
4
.  This will allow identification of cell 
proliferation and cell cycle regulation within in cancer cells.  Analysis of Myc phosphorylation 
sites will allow determination of downstream Myc targets that will help further unravel the anti-
cancer properties of DHA.  A β-actin antibody will also be used to detect β-actin expression 
levels implicated in the formation of tumor cells
4
.  The use of these antibodies will help identify 
Myc protein expression and how it coincides with cell proliferation and apoptosis.  
Myc isoforms act as regulators of cell processes, such as growth, proliferation, and 
apoptosis.  These Myc family residues were originally identified due to their cancer-inducing 
properties
4
.  c-Myc is capable of encoding transcriptional factors that can lead to overexpression 
of this mutated gene associated with tumorigenesis.  Additionally, the c-Myc isoform has been 
found to contain apoptotic properties
6,7
.  Analysis of these c-Myc isoforms properties will further 
help better understand of its roles in apoptosis and tumorigenesis in breast cancer.  This project 
will entail an investigation into how this is happening and examine the functional consequence of 






 Isolation of Docosahexanoic Acid (DHA) and Linoleic Acid (LA).  Inhibitors were thawed 
for the cell lysis buffer (Na3VO4 was at -20° C and Phosphatase Cocktail was at 4° C).  The 
appropriate amount of cell lysis buffer was made with 1 mL of GTP Lysis Buffer Stock mixed 
with 20 uL of PMSF, 20 uL of Na3VO4, 10 ul if Aprotonin, 10 uL of NaF, and 10 uL of 
Protease Cocktail.  The media was then aspirated from the cells.  Cells were washed twice with 
ice cold dPBS, which the cells were aspirated after each wash.  Accumulated excess PBS was 
then aspirated.  50 uL of cell lysis buffer was added to the cells, cells were scraped thoroughly, 
and the cell lysate was collected.   Cells were centrifuged at 12,000 x g for 5 minutes.  The 
supernatant was finally transferred to storage and lysates were ready to be assayed for 
determination of protein concentration.   
 Quanitification of protein concentration in Docosahexanoic Acid and Linoleic Acid.  
Quantification of protein concentration in DHA was determined by protein assay.  The protein 
samples and standards were thawed at room temperature.  1 ug, 2.5 ug, 5 ug, 10 ug, and 20 ug of 
standard in triplicate (1 ug/ul stock was added to 20 ul for 20 ug standard, 10 uL of stock added 
to 10 uL of dH2O for the 10 ug standard, and vice versa) were added to a 96-well assay plate.  2 
uL of the protein samples and 18 uL of dH2O were added in triplicate.  25 uL of Protein Assay 
Reagent A and B were added to all the samples and standards.  The standards and samples sat at 
room temperature for 5-30 minutes.  The standards and samples were analyzed via protein assay 
at optical density 650 nM. 
 Protein Assay of Docosahexanoic Acid and Linoleic Acid.  The protein samples were 
assayed in standardized amounts of 25 ug and 50 ug.  Appropriate amounts of lysis buffer were 
added to the ethanol standard, DHA and LA (Table 1).  Additionally, 7 uL of loading buffer was 
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added to the standardized 25 ug amount and 8 uL was added to the standardized 50 ug.  One set 
of the 25 ug standardized amounts and one set of the 50 ug were obtained for Western Blot 
analysis.   
 Isolation of Docosahexanoic Acid and Linoleic Acid in A-549 and BT-474 cell lines.  50 
ug of ethanol, DHA and LA were loaded into gel for Western Blot analysis.  The proteins were 
run at 90V for 2 hours and then rinsed with dH2O.  The gel was then transferred to a 
Nitrocellulose membrane. 40 mL of the 20x Transfer Buffer Stock was made with 200 mL of 
methanol and 760 mL of dH2O.  The proteins were then transferred at 35V for 1 hour in 
NUPAGE transfer buffer.  10 mL of 5% milk in TBS-T (Tris-Buffered Saline and Tween) 
blocking buffer was used for antibody dilutions and wash volumes.  The proteins were blocked 
for 1 hour at room temperature.  The proteins were then washed 3 times with TBS-T for 5 
minutes at room temperature.  The proteins were treated with secondary antibodies of rabbit in 
Myc and two phosphorylated c-Myc proteins, as well as treatment of mouse antibody in β-actin.   
0.6 g of milk was mixed with 20 mL of TBS-t and 4 mL of mouse secondary antibody.  1.2 g of 
milk was mixed with 40 mL of TBS-T and 8 uL of rabbit secondary antibody.  4 mL of ECL 
reagent was used per blot containing our desired proteins.  The membranes were finally analyzed 
in a dark room to expose to film in order to develop the Western Blot results. 
 Design of Primer sequences for quantitative Real-Time PCR.  Primers were designed 
using Primer3 Input
8





 Quantification of cDNA in A-549 and BT-474 Cell Lines via quantitative Real-Time PCR. 
A-494 and BT-474 cells were treated with either 100uM of LA, DHA or an equal volume of 
ethanol for 4 hours.  Total RNA was isolated and purified using RNeasy mini kit (Qiagen) 
following the manufacturer’s protocol.  cDNA was then synthesized using cDNA Synthsis VILO 
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kit (Invitrogen).  Quantities of cDNA were measured by quantitative real-time PCR on a CFX96 
Real-Time PCR System (Bio-Rad).  Reaction used SYBR green FAST master mix (Applied 
Biosystems).  The relative abundance of mRNA was determined by comparative Ct method
7

























Figure 1: PUFA Effect on Myc Phosphorylation in vitro. Two in vitro models, A-549 and BT-
474 cell lines, were treated with 100uM LA and DHA or an equal volume of ethanol for 48 
hours.  Cells were lysed and proteins were assayed followed by a separation by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis. Proteins were electroblotted on a nitrocellulose 
membranes, followed by immunoblotting of pMyc (S62), pMyc (T58-S62), Myc, and β-actin 





Figure 2: PUFA Effect on Myc Phosphorylation in vitro. Two in vitro models, A-549 and BT-
474 cell lines, were treated with 100uM LA and DHA or an equal volume of ethanol for 48 
hours.  Cells were lysed and proteins were assayed followed by a separation by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis. Proteins were electroblotted on a nitrocellulose 
membranes, followed by immunoblotting of pMyc (S62), pMyc (T58-S62), Myc, and β-actin 












Figure 3: GLUT-Family Protein Expression Upon PUFA Supplementation.  A-549 and BT-474 
cells were treated with 100uM LA and DHA or an equal volume of  ethanol for 48 hours.  Cells 
were lysed and proteins were assayed followed by a  separation by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. Proteins were electroblotted on a nitrocellulose membranes, 
followed by immunoblotting of GLUT-1, GLUT-4, and beta-actin antibodies. Proteins were 















Table 1: Primer sequences for quantitative real-time PCR.  Primers were designed using Primer3 
Input
8






    
                               Gene Primer Sets        
      
         VMYC        
Forward        ATCACCATCACACCACCTGA        
Reverse        CTCAAATGCACCCGAGAAAT        











         MYCN        
Forward        ACACCCTGAGCGATTCAGAT        
Reverse        AGGCATCGTTTGAGGATCAG        
   










         MYCL1 variant 2        
Forward        ATGGAGGACAGTTTGGGTGT        
Reverse        ACCCTTGCAACAGGAAATTG        
   










         beta-Actin        
Forward        CGTCTTCCCCTCCATCG        
Reverse        CTCCTTAATGTCACGCAC        





Figure 4: BT-474 cells were treated with either 100uM of LA, DHA or an equal volume of 
EtOH for 48h.  Total RNA was isolated and purified using RNeasy mini kit (Qiagen) following 
the manufacturer’s protocol.  cDNA was then synthesized using cDNA Synthsis VILO kit 
(Invitrogen).  Quantities of cDNA were measured by quantitative real-time PCR on a CFX96 
Real-Time PCR System (Bio-Rad).  The conditions for the reaction have been described by 
(Mouradian et al., not published).  Reaction used SYBR green FAST master mix (Applied 
Biosystems).  The primers that were used are listed in Table 1.  The relative abundance of 
mRNA was determined by comparative Ct method
7
.  Data represents n=3 independent 












 Results obtained for both A-549 (human lung cancer adenocarcinoma derived cell line) 
and BT-474 (human breast cancer cell line) in response to linoleic acid and docosahexanoic acid 
were undesired.  In Figure 1, neither phosphorous c-Myc blots showed any protein expression.  
This may have been due to short exposure in a tap blot before exposing and developing the film.  
The results would have turned out more desirable if the phosphorylated c-Myc blots were left 
overnight in the tap blot prior to developing.  Whereas, the β-actin control blot did not show 
clear results and this may have been due to a lengthy tap blot prior to developing.  β-actin is 
known to have a highly strong signal that it only requires about 30 seconds to 2 minutes in the 
tap blot before exposure to the film.  Finally, the Myc protein blot did not successfully express in 
neither ethanol, LA and DHA.  The bands were difficult to distinguish between ethanol and LA 
and it shows that there may have been a lack of DHA concentration in the solution.  The desired 
results should result with an upregulation in DHA in both p c-Myc protein residues, while there 
should be a down regulation in LA.  The phosphorous c-Myc protein residues are to assist in 
investigating the role of T58 and T58/S62 c-Myc phosphorylation sites in cell proliferation. The 
overall trend of these proteins do not seem to show desired results, thus, we cannot successfully 
conclude nor determine Myc protein and mRNA expression by DHA.  Possible sources of error 
could have been to due transferring of the protein in the wrong direction away from the blot, not 
enough transfer time, short exposure times, and not enough wetting or calibration time.  
Depending upon the type of blot, nitrocellulose versus polyvinylidene difluoride (PVDF), results 
could be greatly distorted.  Nitrocellulose is typically only good for one round of stripping before 
it begins to break down and can lose some protein.  Additionally, phospho-antibodies are hard to 
work with and do not give a large amount of signal. 
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 However, in Figure 2, we were able to obtain the desired results for the phospho-Myc and 
total Myc residues in response to LA and DHA.  These results obtained are expected for both A-
549 and BT-474 cell lines. DHA expresses an upregulation in both cell lines for both phospho-
Myc residues, but not for total Myc. These results confirm enhancement of the phosphorylation 
of Myc and indicates phosphorylation of T58 and S62 are differentially affects c-Myc activity.  
Since phosphorylation of Myc induces tumorigenesis, these results have shown that DHA 
prevents the phosphorylation at these sites.  Due to this enhancement, we can conclude that DHA 
is successfully altering Myc and c-Myc expression. These alterations exhibit anti-cancer 
outcomes, such as preventing apoptosis and cell proliferation.  Moreover, in Figure 3, DHA 
expresses a downregulation in both cell lines for the GLUT-1 residue only.  There seems to be no 
significant difference between LA and DHA in the GLUT-4 residue, thus, we can exempt DHA 
have any affect on GLUT-4 activity.  Downregulation of DHA in GLUT-1 illustrates low 
expression of the GLUT-1 glucose transporter, which results in inhibition of tumor cell growth 
and glucose transporter protein expression in cancer cells.  Overall, recognition of the 
upregulation in the phospho-Myc residues and downregulation in the GLUT-1 glucose 
transporter indicates that there may be a correlation between Myc and GLUT in glycolysis and 
its mechanistic roles in cancer. 
Our next approach was designing primers specific to various Myc isoforms.  Primer 
efficiencies were performed to determine how efficient the primers are for other isoforms other 
than c-Myc (Table 1). Primer efficiencies have been performed to determine how efficient the 
primers are for other isoforms other than c-Myc and whether these primers could efficiently 
select and identify other isoforms. With the proper primer sets unique and specific to Myc, it is 
possible to determine the mRNA product to a target gene(s), in this case, are the various Myc 
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isoforms.  Having the correct primer pair set is crucial in determining any mRNA product.  After 
selecting a gene of interesting, we use the mRNA sequence (NCBI) of the gene to select the 
primer pair set, either from used published primers or designing our own primers. Based on the 
sequence, we select both a forward and reverse primer (which is the reverse compliment of the 
sequence).  Once we received the primer pair set, we resuspended and diluted them to make a 
working stock.  Using known concentrations of cDNA (template), we ran a standard curve of 
primers (with multiple sets of varied primer concentrations) to determine the optimal primer 
efficiency to quantitate the mRNA of my experimental groups.  However, the qrtPCR results 
were successfully obtained solely for the BT-474 cell line and not for A-549. Figure 4 shows 
expected results of increased mRNA expression of c-Myc in response to DHA.  This suggests 
that DHA has the ability to inhibit proliferation in human breast cancer cells.   
For future directions, having selected the proper primer sets specific to Myc will provide 
possible findings of Myc isoforms function as well as which other isoforms(s) besides c-Myc is 
responsible in regulating cell growth and apoptosis in breast cancer.  We could also determine 
why Myc is being upregulated and further investigate phosphorylation sites of Myc, which is 
crucial for determining the downstream targets of Myc.  These research findings will provide a 
better understanding of the anti-cancer properties of DHA and examine the consequences of 
these alterations in breast cancer.  Contributions to this research that has vast benefits by 
combining nutritional supplementation with conventional cancer therapies can one day improve 
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